November 2, 2009
CTI Clinical Trial and Consulting Services (CTI) announces the
acquisition of CRS Clinical Research Services and CRS – Staff Leasing Services (CRS), a clinical research organization headquartered in Northern Germany. CTI will incorporate all CRS employees into its current European operations and maintain the CRS headquarters located near Hamburg, Germany. CTI is planning to augment its coverage in Germany with the opening of an additional office in the southern region of the country in the coming months.
CRS is a full service, therapeutically-focused clinical research organization, with an emphasis on phase II and phase III clinical trials. Therapeutic areas of focus include infectious disease, oncology, and autoimmune diseases. CRS has managed clinical trials for large pharmaceutical companies, biotechnology companies, and for non-profit organizations across Western Europe.
“The addition of the CRS management and research teams will significantly advance CTI’s current expansion in Europe,” says Timothy Schroeder, CTI President and CEO. “The primary therapeutic focus of CRS has been immunology and oncology, which complements our critically ill population expertise well. CTI also looks forward to maintaining and developing the business relationships CRS has established and maintained for nearly a decade through its operations across Europe.”
Specific terms of the acquisition will not be released.